104th Day Of Lockdown

Maharashtra2119871152629026 Tamil Nadu114978665711571 Delhi100823720883115 Gujarat36858263231967 Uttar Pradesh2770718761785 Telangana2390212703295 Karnataka234749849372 West Bengal2212614711757 Rajasthan2026315965459 Andhra Pradesh200198920239 Haryana1750413335276 Madhya Pradesh1528411579617 Bihar12140901497 Assam11737743414 Odisha9526648648 Jammu and Kashmir84295255132 Punjab64914494132 Kerala5623334128 Chhatisgarh3207257814 Uttarakhand3161258642 Jharkhand2815204520 Goa181310617 Tripura158012061 Manipur13897330 Himachal Pradesh107074610 Puducherry101148014 Nagaland5782280 Chandigarh4874016 Arunachal Pradesh269781 Mizoram191130 Sikkim125650 Meghalaya80431
Business Companies 06 Jun 2020 Pharma major Divi� ...

Pharma major Divi's Labs reports 32.96 per cent rise net profit

PTI
Published Jun 6, 2020, 5:16 pm IST
Updated Jun 6, 2020, 5:20 pm IST
Consolidated net profit was up to Rs 388.23 crore for the quarter ended March 31, 2020
Divi's Labs
 Divi's Labs

New Delhi: Drug firm Divi's Laboratories on Saturday reported a 32.96 per cent rise in its consolidated net profit to Rs 388.23 crore for the quarter ended March 31, 2020. The company had posted a net profit of Rs 291.97 crore for the same period previous fiscal, Divi's Labs said in a BSE filing.

Consolidated total income of the company stood at Rs 1,466.44 crore for the quarter under consideration. It was Rs 1,307.97 crore for the same period year ago.

 

Net profit for the fiscal year ended March stood at Rs 1,376.54 crore as against Rs 1,352.74 crore in the previous fiscal, Divi's Labs said.

For the last fiscal, its total income stood at Rs 5,584.05 crore. It was Rs 5,101.89 crore in the previous fiscal, it added.

The company's board has declared and paid an interim dividend of Rs 16 per share for the financial year 2019-20. No final dividend is recommended. The total dividend payout for the current year amounted to Rs 512.06 crore including dividend tax, Divi's Labs said.

...
Location: India, Telangana, Hyderabad




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT